Literature DB >> 21450999

Antibodies to Merkel cell polyomavirus correlate to presence of viral DNA in the skin.

Helena Faust1, Diana V Pastrana, Christopher B Buck, Joakim Dillner, Johanna Ekström.   

Abstract

To validate whether Merkel cell polyomavirus (MCV) serology correlates with MCV infection, we compared real-time polymerase chain reaction results for MCV DNA on fresh-frozen biopsy specimens from various skin lesions and healthy skin from 434 patients to MCV serology results using viruslike particles (VLPs) and MCV neutralization assays. Sixty-five percent of participants were MCV seropositive and 18% were MCV DNA positive. The presence of antibodies was correlated with the presence of virus DNA (odds ratio, 27.85 [95% confidence interval, 6.6-166.5]), with 97% of patients who tested positive for MCV DNA being MCV seropositive. VLP antibody levels correlated to neutralization titers (r=.72), and high antibody levels correlated to high MCV load (P<.01).
© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21450999     DOI: 10.1093/infdis/jiq173

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.

Authors:  Shailender Bhatia; Olga Afanasiev; Paul Nghiem
Journal:  Curr Oncol Rep       Date:  2011-12       Impact factor: 5.075

Review 2.  A cornucopia of human polyomaviruses.

Authors:  James A DeCaprio; Robert L Garcea
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

3.  Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus.

Authors:  Jérôme T J Nicol; Rémy Robinot; Audrey Carpentier; Giovanni Carandina; Elisa Mazzoni; Mauro Tognon; Antoine Touzé; Pierre Coursaget
Journal:  Clin Vaccine Immunol       Date:  2013-01-09

Review 4.  The conundrum of causality in tumor virology: the cases of KSHV and MCV.

Authors:  Patrick S Moore; Yuan Chang
Journal:  Semin Cancer Biol       Date:  2013-12-01       Impact factor: 15.707

5.  Merkel Cell Polyomavirus Infection Induces an Antiviral Innate Immune Response in Human Dermal Fibroblasts.

Authors:  Nathan A Krump; Ranran Wang; Wei Liu; June F Yang; Tongcui Ma; Jianxin You
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

Review 6.  Review on the relationship between human polyomaviruses-associated tumors and host immune system.

Authors:  Serena Delbue; Manola Comar; Pasquale Ferrante
Journal:  Clin Dev Immunol       Date:  2012-03-25

7.  Diagnostic methods for and clinical pictures of polyomavirus primary infections in children, Finland.

Authors:  Tingting Chen; Laura Tanner; Ville Simell; Lea Hedman; Marjaana Mäkinen; Mohammadreza Sadeghi; Riitta Veijola; Heikki Hyöty; Jorma Ilonen; Mikael Knip; Jorma Toppari; Olli Simell; Maria Söderlund-Venermo; Klaus Hedman
Journal:  Emerg Infect Dis       Date:  2014-04       Impact factor: 6.883

8.  Characterization of self-assembled virus-like particles of Merkel cell polyomavirus.

Authors:  Tian-Cheng Li; Kenji Iwasaki; Harutaka Katano; Michiyo Kataoka; Noriyo Nagata; Kazumi Kobayashi; Tetsuya Mizutani; Naokazu Takeda; Takaji Wakita; Tetsuro Suzuki
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

9.  Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis.

Authors:  Paul W Harms; Rajiv M Patel; Monique E Verhaegen; Thomas J Giordano; Kevin T Nash; Craig N Johnson; Stephanie Daignault; Dafydd G Thomas; Johann E Gudjonsson; James T Elder; Andrzej A Dlugosz; Timothy M Johnson; Douglas R Fullen; Christopher K Bichakjian
Journal:  J Invest Dermatol       Date:  2012-12-06       Impact factor: 8.551

10.  The role of the immune response in merkel cell carcinoma.

Authors:  Pierre L Triozzi; Anthony P Fernandez
Journal:  Cancers (Basel)       Date:  2013-02-28       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.